Announce Date | 05/08/2025 |
EPS Normalized Actual | $-0.14 (Miss by $-0.01) |
EPS GAAP Actual | $-0.14 (Miss by $-0.01) |
Revenue Actual | $0.160033B |
Revenue Surprise | Beat by $160.033M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.13681 |
EPS GAAP Estimate | $-0.13681 |
Revenue Estimate | $0.154870861B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | -0.16 | -33.19 | -0.16134 | -0.15684 | 1 |
Dec 2026 | -0.1202 | -44.18 | -0.26 | 0.04941 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.24 | 2.38498 | 0.160033B | 10.14% | 7.24M |
FQ4 2024 (Dec 2024) | -0.062 | -0.062 | 0.163995B | 12.57% | 164M |
FQ3 2024 (Sep 2024) | -0.16 | -0.16 | 0.147755B | 9.87% | 147.76M |
FQ2 2024 (Jun 2024) | -0.16 | -0.16 | 0.144934B | 9.71% | 144.93M |
FQ1 2024 (Mar 2024) | -0.3 | -0.3 | 0.1438B | 1.32% | 143.8M |
FQ4 2023 (Dec 2023) | -0.0002 | -0.0002 | 0.143373B | -11.36% | 143.37M |
FQ3 2023 (Sep 2023) | -0.22 | -0.22 | 0.133172B | -7.16% | 133.17M |
FQ2 2023 (Jun 2023) | -0.41 | -0.41 | 0.130855B | -18.02% | 130.86M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.13681
Consensus Revenue Estimates
0.154870861B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | -0.004434 | -- | -0.00452697 | -0.0043911 | 1 |
FQ2 2027 (Jun 2027) | -0.026816 | -- | -0.02737825 | -0.02655656 | 1 |
FQ1 2027 (Mar 2027) | -0.027601 | -- | -0.0281797 | -0.02733397 | 1 |
FQ4 2026 (Oct 2026) | -0.046643 | -- | -0.04909174 | -0.04328812 | 1 |
FQ3 2026 (Jul 2026) | -0.13303 | -- | -0.14001 | -0.12346 | 1 |
FQ2 2026 (Jun 2026) | 0.003799 | -- | 0.00356051 | 0.00402758 | 0 |
FQ1 2026 (Mar 2026) | -0.057069 | 4025.07 | -0.06050279 | -0.05348638 | 0 |
FQ4 2025 (Oct 2025) | -0.092133 | 32.71 | -0.09696994 | -0.08550618 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.19B | -- | 0.18B | 0.19B | 2 |
FQ2 2027 (Jun 2027) | 0.19B | -- | 0.18B | 0.19B | 2 |
FQ1 2027 (Mar 2027) | 0.19B | -- | 0.19B | 0.2B | 2 |
FQ4 2026 (Oct 2026) | 0.18B | -- | 0.17B | 0.19B | 2 |
FQ3 2026 (Jul 2026) | 0.18B | -- | 0.17B | 0.19B | 2 |
FQ2 2026 (Jun 2026) | 0.18B | -- | 0.17B | 0.19B | 2 |
FQ1 2026 (Mar 2026) | 0.17B | 6.79 | 0.16B | 0.18B | 2 |
FQ4 2025 (Oct 2025) | 0.16B | -0.78 | 0.15B | 0.17B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.14498 | 2.24 | 2.38498 | 106.47% |
FQ4 2024 (Dec 2024) | -0.062 | -0.062 | 100% | |
FQ3 2024 (Sep 2024) | -0.16 | -0.16 | 100% | |
FQ2 2024 (Jun 2024) | -0.16 | -0.16 | 100% | |
FQ1 2024 (Mar 2024) | -0.3 | -0.3 | 100% | |
FQ4 2023 (Dec 2023) | -0.0002 | -0.0002 | 100% | |
FQ3 2023 (Sep 2023) | -0.22 | -0.22 | 100% | |
FQ2 2023 (Jun 2023) | -0.41 | -0.41 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.15B | $0.16B | $7.24M | 4.52% |
FQ4 2024 (Dec 2024) | $0B | $0.16B | $164M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.15B | $147.76M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.14B | $144.93M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.14B | $143.8M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.14B | $143.37M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.13B | $133.17M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.13B | $130.86M | 100% |